No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - THG is to target the booming obesity jab market through a strategic partnership with convenience food producer Greencore Group, it confirmed on Thursday.
Under the terms of the deal, financial details of which were not disclosed, Greencore will produce a range of on-the-go convenience foods, including salads and wraps, under THG's Myprotein sports nutrition brand.
The range will be sold in Sainsbury's supermarkets and convenience stores.
Neil Mistry, chief executive of THG Nutrition, said: "The range builds on the demand of GLP-1 consumers, along with trends towards cleaner nutrition combined with protein-rich foods and snacks.
"This partnership not only widens the reach of the Myprotein brand offering, it brings further significant penetration into offline channels."
Andy Parton, Greencore's chief commercial officer, said: "As demand grows for convenient, nutritious products that support healthier lifestyles, this collaboration allows us to combine Greencore's expertise...with one of the most recognisable brands in sports nutrition."
Used for the treatment of both diabetes and obesity, demand for GLP-1 drugs such as Ozempic and Mounjaro has boomed in recent years. UBS currently expects sales to reach $130bn by the end of the decade, with around 52m patients taking a GLP-1 in 2030, up from 13m in 2024.
Users are advised to increase protein intake, to help prevent muscle loss during rapid weight loss.
The Greencore partnership is the latest in a number of licensing agreements struck by THG for its nutrition brands, including Muller, Iceland and Jimmy's Coffee. It is targeting selling-in over 60m licensed products this year, up from 43m in 2025.
As at 0900 GMT, Greencore was down 5% at 279.25p, while THG was 2% higher at 36.08p.